K. Balabanian, B. Lagane, S. Infantino, K. Chow, J. Harriague et al., The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes, Journal of Biological Chemistry, vol.73, issue.42, pp.35760-35766, 2005.
DOI : 10.1158/0008-5472.CAN-04-2822

C. Bleul, M. Farzan, H. Choe, C. Parolin, I. Clark-lewis et al., The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry, Nature, vol.382, issue.6594, pp.829-833
DOI : 10.1038/382829a0

M. Bosco, M. Puppo, C. Santangelo, L. Anfosso, U. Pfeffer et al., Hypoxia Modifies the Transcriptome of Primary Human Monocytes: Modulation of Novel Immune-Related Genes and Identification Of CC-Chemokine Ligand 20 as a New Hypoxia-Inducible Gene, The Journal of Immunology, vol.177, issue.3, pp.1941-1955, 2006.
DOI : 10.4049/jimmunol.177.3.1941

C. Cavadas, A. Silva, F. Mosimann, M. Cotrim, C. Ribeiro et al., NPY Regulates Catecholamine Secretion from Human Adrenal Chromaffin Cells, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.12, pp.5956-5963, 2001.
DOI : 10.1210/jcem.86.12.8091

URL : https://academic.oup.com/jcem/article-pdf/86/12/5956/9170222/jcem5956.pdf

A. Chrisoulidou and G. Kaltsas, The diagnosis and management of malignant phaeochromocytoma and paraganglioma, Endocrine Related Cancer, vol.14, issue.3, pp.569-585
DOI : 10.1677/ERC-07-0074

URL : http://erc.endocrinology-journals.org/content/14/3/569.full.pdf

S. Cleary, J. Phillips, T. Huynh, K. Pacak, A. Elkahloun et al., , 2007.

, Neuropeptide Y expression in phaeochromocytomas: relative absence in tumours from patients with von Hippel?Lindau syndrome, Journal of Endocrinology, vol.193, pp.225-233

M. Conconi, R. Spinazzi, and G. Nussdorfer, Endogenous Ligands of PACAP/VIP Receptors in the Autocrine???Paracrine Regulation of the Adrenal Gland, International Reviews of Cytology, vol.249, pp.1-51, 2006.
DOI : 10.1016/S0074-7696(06)49001-X

G. Eisenhofer, S. Bornstein, F. Brouwers, N. Cheung, P. Dahia et al., Malignant pheochromocytoma: current status and initiatives for future progress, Endocrine Related Cancer, vol.11, issue.3, pp.423-436, 2004.
DOI : 10.1677/erc.1.00829

E. Meskini, R. Boudouresque, and F. Ouafik, Endocrinology, vol.138, issue.12, pp.5256-5265, 1997.
DOI : 10.1210/endo.138.12.5557

H. Ghzili, L. Grumolato, E. Thouennon, Y. Tanguy, V. Turquier et al., Role of PACAP in the physiology and pathology of the sympathoadrenal system, Frontiers in Neuroendocrinology, vol.29, issue.1, pp.128-141, 2008.
DOI : 10.1016/j.yfrne.2007.10.001

A. Gimenez-roqueplo, N. Burnichon, L. Amar, J. Favier, X. Jeunemaitre et al., RECENT ADVANCES IN THE GENETICS OF PHAEOCHROMOCYTOMA AND FUNCTIONAL PARAGANGLIOMA, Clinical and Experimental Pharmacology and Physiology, vol.63, issue.4, pp.376-379, 2008.
DOI : 10.1038/sj.onc.1209594

E. Grouzmann, C. Gicquel, P. Plouin, M. Schlumberger, E. Comoy et al., Neuropeptide Y and neuron-specific enolase levels in benign and malignant pheochromocytomas, Neuropeptide Y and neuronspecific enolase levels in benign and malignant pheochromocytomas, pp.1833-1835, 1990.
DOI : 10.1002/1097-0142(19901015)66:8<1833::AID-CNCR2820660831>3.0.CO;2-9

E. Grouzmann, M. Fathi, M. Gillet, A. De-torrente, C. Cavadas et al., Disappearance rate of catecholamines, total metanephrines, and neuropeptide Y from the plasma of patients after resection of pheochromocytoma, Clinical Chemistry, vol.47, pp.1075-1082, 2001.

L. Grumolato, A. Elkahloun, H. Ghzili, D. Alexandre, C. Coulouarn et al., Microarray and Suppression Subtractive Hybridization Analyses of Gene Expression in Pheochromocytoma Cells Reveal Pleiotropic Effects of Pituitary Adenylate Cyclase-Activating Polypeptide on Cell Proliferation, Survival, and Adhesion, Endocrinology, vol.144, issue.6, pp.2368-2379, 2003.
DOI : 10.1210/en.2002-0106

L. Grumolato, E. Louiset, D. Alexandre, D. Ait-ali, V. Turquier et al., PACAP and NGF regulate common and distinct traits of the sympathoadrenal lineage: effects on electrical properties, gene markers and transcription factors in differentiating PC12 cells, European Journal of Neuroscience, vol.93, issue.Suppl. 3, pp.71-82, 2003.
DOI : 10.1016/S0306-4522(99)00108-6

J. Guillemot, D. Ait-ali, V. Turquier, M. Montero-hadjadje, A. Fournier et al., Involvement of multiple signaling pathways in PACAP-induced EM66 secretion from chromaffin cells, Regulatory Peptides, vol.137, issue.1-2, pp.79-88, 2006.
DOI : 10.1016/j.regpep.2006.04.023

URL : https://hal.archives-ouvertes.fr/hal-01706412

D. Hansel, B. Eipper, and G. Ronnett, Neuropeptide Y functions as a neuroproliferative factor, Nature, vol.127, issue.6831, pp.940-944, 2001.
DOI : 10.1210/endo-127-1-133

H. Hao, O. Khalimonchuk, M. Schraders, N. Dephoure, J. Bayley et al., SDH5, a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma, Science, vol.48, issue.3, pp.1139-1142, 2009.
DOI : 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A

L. Helman, P. Cohen, S. Averbuch, M. Cooper, H. Keiser et al., Neuropeptide Y expression distinguishes malignant from benign pheochromocytoma., Journal of Clinical Oncology, vol.7, issue.11, pp.1720-1725, 1989.
DOI : 10.1200/JCO.1989.7.11.1720

Y. Ichiki, K. Kitamura, K. Kangawa, M. Kawamoto, H. Matsuo et al., Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma, FEBS Letters, vol.14, issue.1, pp.6-10, 1994.
DOI : 10.1016/0306-4522(85)90156-3

T. Ishikawa, J. Chen, J. Wang, F. Okada, T. Sugiyama et al., Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis, Oncogene, vol.22, issue.8, pp.1238-1242, 2003.
DOI : 10.1038/35025215

K. Isobe, I. Tatsuno, T. Yashiro, T. Nanmoku, K. Takekoshi et al., Expression of mRNA for PACAP and its receptors in intra- and extra-adrenal human pheochromocytomas and their relationship to catecholamine synthesis, Regulatory Peptides, vol.110, issue.3, pp.213-217, 2003.
DOI : 10.1016/S0167-0115(02)00209-4

I. Kaafarani, S. Fernandez-sauze, C. Berenguer, O. Chinot, C. Delfino et al., Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth of human tumor xenografts in mice, The FASEB Journal, vol.23, issue.10, pp.3424-3435, 2009.
DOI : 10.1016/S0301-472X(02)00890-1

URL : https://hal.archives-ouvertes.fr/hal-01848088

S. Kapas and A. Clark, Identification of an Orphan Receptor Gene as a Type 1 Calcitonin Gene-Related Peptide Receptor, Biochemical and Biophysical Research Communications, vol.217, issue.3, pp.832-838, 1995.
DOI : 10.1006/bbrc.1995.2847

K. Kitamura, K. Kangawa, M. Kawamoto, Y. Ichiki, S. Nakamura et al., Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human Pheochromocytoma, Biochemical and Biophysical Research Communications, vol.192, issue.2, pp.553-560, 1993.
DOI : 10.1006/bbrc.1993.1451

J. Kitlinska, K. Abe, L. Kuo, J. Pons, M. Yu et al., Differential Effects of Neuropeptide Y on the Growth and Vascularization of Neural Crest???Derived Tumors, Cancer Research, vol.65, issue.5, pp.1719-1728, 2005.
DOI : 10.1158/0008-5472.CAN-04-2192

M. Korner, B. Waser, and J. Reubi, High Expression of Neuropeptide Y Receptors in Tumors of the Human Adrenal Gland and Extra-Adrenal Paraganglia, Clinical Cancer Research, vol.10, issue.24, pp.8426-8433, 2004.
DOI : 10.1158/1078-0432.CCR-04-0821

A. Ladoux and C. Frelin, Coordinated Up-regulation by Hypoxia of Adrenomedullin and One of Its Putative Receptors (RDC-1) in Cells of the Rat Blood-Brain Barrier, Journal of Biological Chemistry, vol.119, issue.51, pp.39914-39919, 2000.
DOI : 10.1111/j.1476-5381.1996.tb16050.x

E. Lee, M. Michalkiewicz, J. Kitlinska, I. Kalezic, H. Switalska et al., Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles, Journal of Clinical Investigation, vol.111, issue.12, pp.1853-1862, 2003.
DOI : 10.1172/JCI16929

J. Lenders, G. Eisenhofer, M. Mannelli, and K. Pacak, Phaeochromocytoma, The Lancet, vol.366, issue.9486, pp.665-675, 2005.
DOI : 10.1016/S0140-6736(05)67139-5

S. Madden, B. Cook, M. Nacht, W. Weber, M. Callahan et al., Vascular gene expression in nonneoplastic and malignant brain. American Journal of Pathology, vol.165, pp.601-608, 2004.

E. Maderna, A. Salmaggi, C. Calatozzolo, L. Limido, and . Pollo, Nestin, PDGFR-??, CXCL12 and VEGF in gliomapatients: Different profiles of (Pro-Angiogenic) molecule expression are related with tumor grade and may provide prognostic information, Cancer Biology & Therapy, vol.6, issue.7, pp.1018-1024, 2007.
DOI : 10.4161/cbt.6.7.4362

W. Manger, Diagnosis and management of pheochromocytoma ??? recent advances and current concepts, Kidney International, vol.70, pp.30-35, 2006.
DOI : 10.1038/sj.ki.5001974

G. Mazzocchi, G. Albertin, P. Andreis, G. Neri, L. Malendowicz et al., Distribution, functional role, and signaling mechanism of adrenomedullin receptors in the rat adrenal gland, Peptides, vol.20, issue.12, pp.1479-1487, 1999.
DOI : 10.1016/S0196-9781(99)00159-X

L. Mclatchie, N. Fraser, M. Main, A. Wise, J. Brown et al., RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor, Nature, vol.141, issue.6683, pp.333-339, 1998.
DOI : 10.1084/jem.183.6.2437

Z. Miao, K. Luker, B. Summers, R. Berahovich, M. Bhojani et al., CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature, Proceedings of the National Academy of Sciences, vol.100, issue.20, pp.15735-15740, 2007.
DOI : 10.1073/pnas.1933744100

Y. Mizrachi, P. Lelkes, R. Ornberg, G. Goping, and H. Pollard, Specific adhesion between pheochromocytoma (PC12) cells and adrenal medullary endothelial cells in co-culture, Cell and Tissue Research, vol.256, issue.2, pp.365-372, 1989.
DOI : 10.1007/BF00218894

M. Montero-hadjadje, H. Vaudry, V. Turquier, J. Leprince, D. Rego et al., Localization and characterization of evolutionarily conserved chromogranin A-derived peptides in the rat and human pituitary and adrenal glands, Cell and Tissue Research, vol.310, issue.2, pp.223-236, 2002.
DOI : 10.1007/s00441-002-0625-9

URL : https://hal.archives-ouvertes.fr/hal-01706424

T. Nishikimi, Adrenomedullin in the Kidney-Renal Physiological and Pathophysiological Roles, Current Medicinal Chemistry, vol.14, issue.15, pp.1689-1699, 2007.
DOI : 10.2174/092986707780830943

J. Pons, J. Kitlinska, J. H. Lee, and E. Zukowska, Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the ??-adrenergic system, Canadian Journal of Physiology and Pharmacology, vol.83, issue.2, pp.177-185, 2003.
DOI : 10.1161/01.RES.83.2.187

D. Ribatti, M. Conconi, and G. Nussdorfer, Nonclassic Endogenous Novel Regulators of Angiogenesis, Pharmacological Reviews, vol.59, issue.2, pp.185-205, 2007.
DOI : 10.1124/pr.59.2.3

URL : http://pharmrev.aspetjournals.org/content/pharmrev/59/2/185.full.pdf

P. Rocchi, F. Boudouresque, A. Zamora, X. Muracciole, E. Lechevallier et al., Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines, Cancer Research, vol.61, pp.1196-1206, 2001.
URL : https://hal.archives-ouvertes.fr/hal-01710707

J. Rosmaninho-salgado, I. Araujo, A. Alvaro, A. Mendes, L. Ferreira et al., Regulation of catecholamine release and tyrosine hydroxylase in human adrenal chromaffin cells by interleukin-1??: role of neuropeptide Y and nitric oxide, Journal of Neurochemistry, vol.44, issue.Suppl, pp.911-922, 2009.
DOI : 10.1161/01.RES.84.5.587

P. Des-senanayake, J. Denker, E. Bravo, and R. Graham, Production, characterization, and expression of neuropeptide Y by human pheochromocytoma., Journal of Clinical Investigation, vol.96, issue.5, pp.2503-2509, 1995.
DOI : 10.1172/JCI118310

L. Taupenot, S. Mahata, H. Wu, and D. Connor, , 1998.

, Peptidergic activation of transcription and secretion in chromaffin cells Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP), Journal of Clinical Investigation, vol.101, pp.863-876

E. Thouennon, A. Elkahloun, J. Guillemot, A. Gimenez-roqueplo, J. Bertherat et al., Identification of Potential Gene Markers and Insights into the Pathophysiology of Pheochromocytoma Malignancy, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.12, pp.4865-4872, 2007.
DOI : 10.1210/jc.2007-1253

URL : https://hal.archives-ouvertes.fr/hal-01706427

H. Timmers, A. Gimenez-roqueplo, M. Mannelli, and K. Pacak, Clinical aspects of SDHx-related pheochromocytoma and paraganglioma, Endocrine Related Cancer, vol.16, issue.2, pp.391-400, 2009.
DOI : 10.1677/ERC-08-0284

V. Turquier, Y. L. Grumolato, L. Alexandre, D. Fournier, A. Vaudry et al., Pituitary Adenylate Cyclase-Activating Polypeptide Stimulates Secretoneurin Release and Secretogranin II Gene Transcription in Bovine Adrenochromaffin Cells through Multiple Signaling Pathways and Increased Binding of Pre-Existing Activator Protein-1-Like Transcription Factors, Molecular Pharmacology, vol.60, issue.1, pp.42-52, 2001.
DOI : 10.1124/mol.60.1.42

B. Uzan, A. Villemin, J. Garel, and M. Cressent, Adrenomedullin is anti-apoptotic in osteoblasts through CGRP1 receptors and MEK-ERK pathway, Journal of Cellular Physiology, vol.15, issue.1, pp.122-128, 2008.
DOI : 10.4049/jimmunol.176.9.5548

J. Vandesompele, D. Preter, K. Pattyn, F. Poppe, B. Van-roy et al., Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes, Genome Biology, vol.3, p.34, 2002.

D. Vaudry, A. Falluel-morel, S. Bourgault, M. Basille, D. Burel et al., Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery, Pharmacological Reviews, vol.61, issue.3, pp.283-357, 2009.
DOI : 10.1124/pr.109.001370

URL : https://hal.archives-ouvertes.fr/hal-02058111

J. Wang, Y. Shiozawa, J. Wang, Y. Wang, Y. Jung et al., The Role of CXCR7/RDC1 as a Chemokine Receptor for CXCL12/SDF-1 in Prostate Cancer, Journal of Biological Chemistry, vol.165, issue.7, pp.4283-4294, 2008.
DOI : 10.1074/jbc.M508234200

L. Yon, J. Guillemot, M. Montero-hadjadje, L. Grumolato, J. Leprince et al., Malignant Tumors, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.6, pp.2579-2585, 2003.
DOI : 10.1210/jc.2002-021748

URL : https://hal.archives-ouvertes.fr/hal-01706414

Z. Zeng, D. Liu, H. Li, X. Fan, G. Liu et al., Expression and Effect of Adrenomedullin in Pheochromocytoma, Annals of the New York Academy of Sciences, vol.42, issue.1, pp.270-276, 2006.
DOI : 10.1016/0014-5793(94)80106-1

C. Ziegler, J. Brown, A. Schally, A. Erler, L. Gebauer et al., Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: Antiproliferative effects of peptide analogues, Proceedings of the National Academy of Sciences, vol.31, issue.5, pp.15879-15884, 2009.
DOI : 10.1097/01.CCM.0000063282.83188.3D